1. Home
  2. BNTC vs SOPH Comparison

BNTC vs SOPH Comparison

Compare BNTC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.55

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.19

Market Cap

330.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
SOPH
Founded
1995
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.7M
330.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BNTC
SOPH
Price
$11.55
$5.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$27.67
$7.00
AVG Volume (30 Days)
171.7K
214.2K
Earning Date
02-13-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$73,297,000.00
Revenue This Year
N/A
$18.48
Revenue Next Year
N/A
$15.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.66
52 Week Low
$9.70
$2.58
52 Week High
$17.15
$5.55

Technical Indicators

Market Signals
Indicator
BNTC
SOPH
Relative Strength Index (RSI) 40.27 57.61
Support Level $11.40 $5.00
Resistance Level $12.55 $5.55
Average True Range (ATR) 0.84 0.34
MACD -0.06 0.04
Stochastic Oscillator 10.69 57.05

Price Performance

Historical Comparison
BNTC
SOPH

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: